SoftBank and Hanwha-backed biomanufacturer Zymergen floated at the top of its range in an upsized offering following over $870m in venture funding.

The Medtronic and Johnson & Johnson-backed epilepsy treatment system provider floated at the top of its range and saw its shares rise 47% on their first day.

CapitalG is selling $85.5m of shares in the robotic process automation technology producer as part of an offering sized at almost $1.34bn.

The Fosun-backed eye disease treatment developer has filed for a $100m initial public offering, having raised over $250m in funding in the past two years.

The CN, Goodyear, Kroger, Mando, Navistar, Nvidia, Sina, Traton, Union Pacific, UPS and US Xpress-backed autonomous truck producer was valued at more than $8.5bn in the IPO.

The Fidelity-backed digital banking software provider has floated on the Nasdaq Global Select Market in a $180m offering priced above its range.

The crypto trading platform has executed a direct listing and is now valued above $85bn, six years after BBVA, New York Stock Exchange, NTT Docomo and USAA backed it at a $490m valuation.

The infectious disease drug developer has applied to float in Hong Kong, which will enable the WuXi AppTec-backed 6 Dimensions Capital to exit.

The NK cancer drug provider has filed to go public in an offering which would enable GC and its GC Labcell subsidiary to exit.

The Tencent-backed video game holding group has applied to float in a Korean initial public offering which could value it at about $18bn.